Jounce Therapeutics

YTD

ALL

Why Robinhood?

You can watch JNCE and buy or sell other stocks, ETFs, and their options commission-free!

About JNCE

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors.

CEO

Kevin C. Tang

CEOKevin C. Tang

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2013

Founded2013

Employees

—

Employees—

JNCE Key Statistics

Market cap

98.95M

Market cap98.95M

Price-Earnings ratio

-1.91

Price-Earnings ratio-1.91

Dividend yield

—

Dividend yield—

Average volume

2.01M

Average volume2.01M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$5.87

52 Week high$5.87

52 Week low

$0.5773

52 Week low$0.5773

People also own

Based on the portfolios of people who own JNCE. This list is generated using Robinhood data, and it’s not a recommendation.